Teoman DOĞRU, Ahmet KARAKAŞ, Nuri KARADURMUŞ, Vedat TURHAN, KENAN SAĞLAM

Lymph node tuberculosis in Non-HIV positive young male patients: Retrospective analysis of 33 cases

AMAÇ: Bu çalışma, lenf nodu tüberkülozlu küçük bir hasta grubunun klinik ve demografik özelliklerinin retrospektif olarak incelenmesi ve mevcut tanı-tedavi yöntemlerinin gözden geçirilmesi amacı ile yapıldı. YÖNTEM: 2000-2003 yılları ararsında lenf nodu tüberkülozu tanısı konmuş otuzüç (31 erkek, 2 kadın, ortalama yaş 24.9 ±5.4) hasta değerlendirildi. BULGULAR: Hiçbir hastada alkol veya uyuşturucu madde kullanımı yoktu. Servikal bölge en sık tutulum gözlenen bölge idi (%84.8). Ağrısız şişlik en sık saptanan başlangıç semptomuydu. (%93.9). Tanı hastaların servikal lenf nodu eksizyonel biyopsisi ile kondu. Hastalar HIV serolojisi açısından negatifti. Uygulanan tüberküloz tedavisi genel olarak iyi tolere edildi. SONUÇ: Bu sonuçlar, ülkemizde tüberkülozun HIV negatif hastalar da dahil olmak üzere lenfadenitlerin önemli bir nedeni olduğunu göstermektedir. Lenf nodu tüberkülozu çoğu hastada kısa sureli kombine antitüberküloz tedaviye iyi yanıt vermektedir.

HIV enfeksiyonu olmayan genç erkek hastalarda lenf nodu tüberkülozu: 33 olgunun retrospektif analizi

AIM: To analysis retrospectively the clinical and demographic characteristics of a small group of patients with lymph node tuberculosis (TB) in Turkey, and review the current diagnostic and therapeutic measures. METHOD: Thirty-three patients (31 male, 2 female; mean age 24.9 ±5.4) diagnosed with lymph node TB between 2000 and 2003 were evaluated. RESULTS: No patient had history of alcohol or drug abuse. Cervical region was the most common involvement site (84.8%). Non-tender swelling was the initial symptom in most of the cases (93.9%). The diagnosis was based on the excisional lymph node biopsy on 93% of cases. No patient was HIV (+). Antituberculous treatment was generally well tolerated. CONCLUSION: This report suggests that TB remains an important etiologic factor for lymphadenitis in HIV negative patients. Lymph node TB responds to short term combined antituberculous treatment in most patients.

PDF

___

1. Maher D, Raviglione MC. The global epidemiologic of tuberculosis: a World Health Organization perspective. Eds: Schlossberg D: Tuberculosis and non-tuberculous mycobacterial infections. 4th ed. Philadelphia. W.B. Saunders company, 1999, p. 104-115.
2. Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004; 120(4): 316-353.
3. Raviglione MC, Narain JP, Kochi A. HIV-associated tuberculosis in developing countries: clinical features, diagnosis and treatment. World Health Organ Bull. 1992; 70(4): 515-526.
4. Mehta JB, Dutt A, Harvill L, Mathews KM. Epidemiology of extrapulmonary tuberculosis. A comparative analysis with pre-AIDS era. Chest 1991; 99(5): 1134-1138.
5. Hill AR, Premkumar S, Brustein S, Vaidya K, Powell S, Li PW, Suster B. Disseminated tuberculosis in the acquired immunodeficiency syndrome era. Am Rev Respir Dis. 1991; 1 44(5): 1164-1170.
6. Yenen OS, Ekinci E, Aydilek R, Baydar I. HIV infection and tuberculosis in Turkey. Chest. 1988; 94(3): 674.
7. Ozbay B, Uzun K. Extrapulmonary tuberculosis in high prevalance of tuberculosis and low prevalance of HIV. Clin Chest Med. 2002; 23(2): 351-354.
8. Demiralay R. Some epidemiological features of extrapulmonary tuberculosis registered in the tuberculous struggle dispensaries in Isparta. Tuberk Toraks. 2003; 51(1): 33-39.
9. Dandapat MC, Mishra BM, Dash SP, Kar PK. Peripheral lymph node tuberculosis: a review of 80 cases. Br J Surg. 1990; 77(8): 911-912.
10. Shriner KA, Mathisen GE, Goetz MB. Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls. Clin Infect Dis. 1992; 15(4): 601-605.
11. Chen YM, Lee PY, Su WJ, Perng RP. Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan. Tuber Lung Dis. 1992; 73(6): 368-3671.
12. Fain O, Lortholary O, Djouab M, Amoura I, Babinet P, Beaudreuil J, et al. Lymph node tuberculosis in the suburbs of Paris: 59 cases in adults not infected by the human immunodeficiency virus. Int J Tuberc Lung Dis. 1999; 3(2): 162-165.
13. Thompson MM, Underwood MJ, Sayers RD, Dookeran KA, Bell PRF. Peripheral tuberculous lymphadenopathy: a review of 67 cases. Br J Surg. 1992; 79(8): 763-764.
14. Geldmacher H, Taube C, Kroeger C, Magnussen H, Kirsten DK. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest. 2002; 121(4): 1177-1182.
15. Mert A, Tabak F, Ozaras R, Tahan V, Ozturk R, Aktuglu Y. Tuberculous lymphadenopathy in adults: a review of 35 cases. Acta Chir Belg. 2002; 102(2): 118-121.
16. Alvarez S, McCabe WR. Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine. 1984; 63(1): 25-55.
17. Kent DC. Tuberculous lymphadenitis: Not a localised disease process. Am J Med Sci. 1967; 254(6): 866-874.
18. Lee KC, Tamoi TA, Lalwani AK, Schecter G. Contemporary management of cervical tuberculosis. Laryngoscope. 1992; 102(1): 60-64.
19. Subrahmanyam M. Role of surgery and chemotherapy for peripheral lymph node tuberculosis. Br J Surg. 1993; 80(12): 1547-1548.
20. Artenstein AW, Kim JH, Williams WJ, Chung RC. Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clin Infect Dis. 1995; 20(4): 876-882.
21. Alcantara-Payawal DE, Matsumura M, Shiratori Y, Okudaira T, Gonzalea R, Lopez RA et al. Direct detection of Mycobacterium tuberculosis using polymerase chain reaction assays among patients with hepatic granuloma. J Hepatol. 1997; 27(4): 620-627.
22. Ying M, Ahuja AT, Evans R, King W, Metreweli C. Cervical lymphadenopathy: sonographic differentiation between tuberculous nodes and nodal metastases from non-head and neck carcinomas. J Clin Ultrasound. 1998; 26(8): 383-389.
23. Ozturk CE, Balbay OA, Kaya D, Ceyhan I, Bulut I, Sahin I. The Resistance to Major Antituberculous Drugs of Mycobacterium tuberculosis Strains Isolated from the Respiratory System Specimens of Tuberculosis Patients in Duzce, Turkey. Jpn J Infect Dis. 2005; 58(1): 47-49.
24. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003; 167(11): 1472-1477.